AATD is caused by genetic mutations in SERPINA1, which encodes alpha-1 antitrypsin (AAT), a serine protease inhibitor (Pi) synthesized mainly in hepatocytes that functions primarily to maintain the protease–antiprotease balance in the lungs [5–8]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.